申请人:UNIV BRITISH COLUMBIA
公开号:WO2016020732A1
公开(公告)日:2016-02-11
The current application relates to a pharmaceutical composition for the treatment or amelioration of a neurological disease, wherein the composition comprises a therapeutically effective amount of a caspase-6 inhibitor which is an arylpropynamide derivative. The composition can be formulated for oral or topical administration, subcutaneous, intravenous, or intramuscular injection, infusion, inhalation, or intrthecal injection.
目前的申请涉及一种用于治疗或改善神经系统疾病的药物组合物,其中该组合物包括治疗有效量的一种caspase-6抑制剂,该抑制剂是一种芳基丙炔酰胺衍生物。该组合物可以制成口服或局部给药、皮下、静脉或肌肉注射、输液、吸入或脑脊液注射剂。